Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul;17(3):971-972.
doi: 10.1007/s13311-020-00869-8.

Commentary: The Multiple Sclerosis Controversy: Is It Escalation or Induction High Efficacy?

Patricia K Coyle  1
Affiliations
Editorial

Commentary: The Multiple Sclerosis Controversy: Is It Escalation or Induction High Efficacy?

Patricia K Coyle. Neurotherapeutics. 2020 Jul.
No abstract available

PubMed Disclaimer

Comment on

  • Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study.
    Prosperini L, Mancinelli CR, Solaro CM, Nociti V, Haggiag S, Cordioli C, De Giglio L, De Rossi N, Galgani S, Rasia S, Ruggieri S, Tortorella C, Capra R, Mirabella M, Gasperini C. Prosperini L, et al. Neurotherapeutics. 2020 Jul;17(3):994-1004. doi: 10.1007/s13311-020-00847-0. Neurotherapeutics. 2020. PMID: 32236822 Free PMC article. Clinical Trial.

References

    1. Filippi M, Bar-Or A, Piehl F, et al. Multiple sclerosis. Nat Rev Dis Primers 2018;4(43): doi: 10.1038/s41572-018-0041-4. - PubMed
    1. Reich DS, Lucchinetti CF, Calabresi PA. N Engl J Med. 2018;378(2):169–180. doi: 10.1056/NEJMra1401483. - DOI - PMC - PubMed
    1. Disease-modifying therapies for MS. National Multiple Sclerosis Society. NationalMSSociety.org/DMT2019. P1–29.
    1. Stankiewicz JM, Weiner HL. An argument for broad use of high efficacy treatments in early multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 2019;7(1). pii: e636. doi: 10.1212/NXI.0000000000000636. - PMC - PubMed
    1. Lunemann JD, Ruck T, Muraro PA, et al. Immune reconstitution therapies: Concepts for durable remission in multiple sclerosis. Nat Rev Neurol. 2020;16(1):56–62. doi: 10.1038/s41582-019-0268-z. - DOI - PubMed